Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial
2017 · The Lancet Oncology · 379 citations
https://doi.org/10.1016/s1470-2045(17)30181-x
T
Takahiro Tsushima
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
249
Papers
4.7K
Citations
33
h-index
84
i10-index
Takahiro Tsushima is an academic researcher from Shizuoka Cancer Center. The author has contributed to research in topics: Esophageal Cancer Research and Treatment & Gastric Cancer Management and Outcomes & Colorectal Cancer Treatments and Studies. The author has an h-index of 33, co-authored 212 publications.
ORCID: 0000-0003-3551-7504Papers by this author
worksEsophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1
2023 · Esophagus · 345 citations
https://doi.org/10.1007/s10388-023-00993-2
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
2018 · Annals of Oncology · 284 citations
https://doi.org/10.1093/annonc/mdy498
Comprehensive registry of esophageal cancer in Japan, 2014
2021 · Esophagus · 74 citations
https://doi.org/10.1007/s10388-021-00879-1
Negative Impact of Skeletal Muscle Wasting After Neoadjuvant Chemotherapy Followed by Surgery on Survival for Patients with Thoracic Esophageal Cancer
2017 · Annals of Surgical Oncology · 60 citations
https://doi.org/10.1245/s10434-017-6020-2
TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma
2020 · BMC Cancer · 52 citations
https://doi.org/10.1186/s12885-020-06716-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat